American Journal of Respiratory and Critical Care Medicine

Rationale: Cohort evidence linking long-term exposure to outdoor particulate air pollution and mortality has come largely from the United States. There is relatively little evidence from nationally representative cohorts in other countries.

Objectives: To investigate the relationship between long-term exposure to a range of pollutants and causes of death in a national English cohort.

Methods: A total of 835,607 patients aged 40–89 years registered with 205 general practices were followed from 2003–2007. Annual average concentrations in 2002 for particulate matter with a median aerodynamic diameter less than 10 (PM10) and less than 2.5 μm (PM2.5), nitrogen dioxide (NO2), ozone, and sulfur dioxide (SO2) at 1 km2 resolution, estimated from emission-based models, were linked to residential postcode. Deaths (n = 83,103) were ascertained from linkage to death certificates, and hazard ratios (HRs) for all- and cause-specific mortality for pollutants were estimated for interquartile pollutant changes from Cox models adjusting for age, sex, smoking, body mass index, and area-level socioeconomic status markers.

Measurements and Main Results: Residential concentrations of all pollutants except ozone were positively associated with all-cause mortality (HR, 1.02, 1.03, and 1.04 for PM2.5, NO2, and SO2, respectively). Associations for PM2.5, NO2, and SO2 were larger for respiratory deaths (HR, 1.09 each) and lung cancer (HR, 1.02, 1.06, and 1.05) but nearer unity for cardiovascular deaths (1.00, 1.00, and 1.04).

Conclusions: These results strengthen the evidence linking long-term ambient air pollution exposure to increased all-cause mortality. However, the stronger associations with respiratory mortality are not consistent with most US studies in which associations with cardiovascular causes of death tend to predominate.

Scientific Knowledge on the Subject

Long-term exposure to ambient levels of fine particulate matter has been associated with increased mortality, particularly from cardiovascular disease, in several US population cohorts. There is less cohort evidence available outside the United States on gaseous pollutants and on respiratory outcomes.

What This Study Adds to the Field

Concentrations of particulate matter, nitrogen dioxide, and sulfur dioxide, but not ozone, were associated with increased all-cause mortality in a large national cohort in England. However, unlike US studies we found larger associations for respiratory rather than cardiovascular causes of death. These findings add to the evidence that from an international perspective there is important heterogeneity in the effects of air pollution on cause-specific mortality.

Epidemiologic studies suggest that long-term exposure to ambient air pollution is associated with increased mortality (1, 2). Much of this evidence comes from cohort studies in the United States where the focus has been on associations with fine particles. In particular, the American Cancer Society (ACS) study (3) and the Six-Cities study (4) have been extensively reanalyzed confirming their initial findings (59). Associations with the air pollution mixtures experienced by populations in Europe (1016) and worldwide (1720) have also been reported.

Where studies have investigated cause-specific mortality, the focus has been on cardiovascular disease (2). By contrast, the evidence for associations with respiratory mortality is less convincing (1) because many studies have lacked statistical power, or used a combined cardiorespiratory outcome because of the smaller number of respiratory deaths (4, 12). A recent report on the global impact of particulate matter with a median aerodynamic diameter less than 2.5 μm (PM2.5) on chronic obstructive pulmonary disease (COPD) was reliant on only three studies, all from the United States (21). Few cohort studies have used large, population-based, nationally representative samples to investigate a range of respiratory and cardiovascular causes separately, or considered a range of criteria pollutants.

In this study, we investigate the associations between long-term exposure to a range of outdoor air pollutants and both all-cause and cause-specific mortality using a national cohort of adults registered with family practitioners in England, using linkage to a national mortality register to provide details on date and underlying cause of death.

The Clinical Practice Research Datalink is a large, validated, and nationally representative database containing anonymized patient data from UK primary care (22). It includes a full longitudinal medical record for each patient consulting their family practitioner including information on diagnoses made within the practice. We selected 205 English practices, recording high-quality data according to Clinical Practice Research Datalink internal standards, which had available linked death registrations from the Office for National Statistics. From these, we identified 836,557 patients aged between 40 and 89 years, fully registered for at least 1 year on January 1, 2003 (23).

The following information was extracted from the electronic patient record and used to construct covariates: age; sex; smoking (non-, ex-, and current smoker, with further categories of 1–19, 20–30, and 40+ cigarettes per day); and body mass index (BMI) (<20, ≥20 and <25, ≥25 and <30, ≥30). The last recorded status before January 1, 2003 was used to code the variables, except for nonsmokers, who were reclassified as ex-smokers if they had older historical codes indicating smoking. A “missing” category was assigned for subjects with no recorded value before 2003. Socioeconomic status (SES) was classified using three separate census measures of deprivation (income, employment, and education), measured on a geographic area of approximately 1,500 people (24). A total of 950 patients had no census information and were dropped from the analyses. Deaths were classified according to the underlying cause on the death certificate (ICD-10): circulatory, I00-I99; coronary heart disease (CHD), I20–25; myocardial infarction, I21–23; stroke, I61, I63–64; heart failure, I50; respiratory, J00-J99; pneumonia, J12–18; COPD, J40–44, J47; and lung cancer, C33–34. We performed sensitivity analyses defining circulatory deaths as any mention on the certificate, and respiratory deaths restricted to where there was no mention of circulatory disease on the certificate.

Annual mean concentrations in 2002 of PM10 and PM2.5, sulfur dioxide (SO2), nitrogen dioxide (NO2), and ozone (O3) for 1-km grid squares covering England were linked anonymously from grid centroid to the nearest residential postcode centroid for each patient (23). The pollutant concentrations were estimated using air dispersion models, developed by AEA Technology (Didcot, Oxfordshire, UK) over the past 10 years (25), for reporting to the UK Government and the European Commission for policy formulation (26). The models for PM10, PM2.5, NO2, and SO2 were constructed by estimating quantities of emissions by sector (e.g., power generation, domestic combustion, road traffic) with subsequent pollution concentrations calculated by summing estimates for pollutant-specific components, such as point and local area sources. O3 maps were constructed by interpolating data from rural monitoring stations and adjusting for effects of altitude and nitrogen oxide emissions. Model validation using national air quality monitors and networks (see Tables E1 and E2 in the online supplement) was good for NO2 (R2 = 0.57–0.80) and O3 (R2 = 0.48–0.71); moderate for PM10 (R2 = 0.29–0.46) and PM2.5 (R2 = 0.23–0.71); but less successful for SO2 (R2 = 0–0.39). Further details on the methodology and validation are provided in the online supplement.

We used Cox proportional hazards models (SAS version 9.1.3; SAS Institute, Inc., Cary, NC) to investigate associations between pollution concentrations in 2002 and subsequent mortality in 2003–2007. We adjusted cumulatively for (1) age and sex; (2) smoking and BMI; and (3) in turn, income, employment, and education. Two-pollutant models were considered only when the correlation coefficient between pollutants was below 0.5. We performed stratified analyses to assess effect modification by the covariates. To account for clustering, the modified sandwich estimate of variance was used to produce robust standard errors. As a sensitivity analysis, we investigated the impact of fitting a random effect for practice in a shared frailty model (Stata version 10.1; StataCorp LP, College Station, TX). To allow comparison across pollutants, hazard ratios (HRs) were quantified for an interquartile range change in each pollutant (Table 1).

TABLE 1. SUMMARY OF ASSIGNED POLLUTANT CONCENTRATIONS FOR STUDY COHORT (N = 835,607)

 Assigned Annual Average Concentration in 2002 (μg/m3)
 PM10PM2.5SO2NO2O3
No. of patients with pollution linkage (%)830,842 (99%)830,842 (99%)823,442 (99%)830,429 (99%)824,654 (99%)
Mean pollution (SD)19.7 (2.3)12.9 (1.4)3.9 (2.1)22.5 (7.4)51.7 (2.4)
Minimum–maximum range12.6–29.88.5–20.20.1–24.24.5–60.844.5–63.0
Interquartile range3.01.92.210.73.0
Practice region means (SD)     
 North (81 practices)19.8 (2.3)13.0 (1.5)4.8 (2.1)23.4 (6.3)50.9 (2.4)
 South (excluding London) (96 practices)19.1 (2.0)12.5 (1.2)3.3 (1.9)19.4 (6.1)52.6 (2.2)
 London (28 practices)22.5 (1.2)14.6 (0.8)3.8 (1.2)33.3 (4.5)50.2 (0.8)
 Test for heterogeneityP < 0.001P < 0.001P < 0.001P < 0.001P < 0.001
Correlation with census socioeconomic scores*     
 Income deprivation0.250.260.110.24−0.11
 Employment deprivation0.150.170.170.16−0.12
 Education deprivation0.140.150.200.05−0.08
Correlation with other pollutants     
 PM2.50.99
 SO20.450.46
 NO20.840.850.37
 O3−0.40−0.39−0.41−0.46
Intraclass correlation by practice0.870.850.770.900.94

Definition of abbreviations: NO2 = nitrogen dioxide; O3 = ozone; PM2.5 = particulate matter with a median aerodynamic diameter less than 2.5 μm; PM10 = particulate matter with a median aerodynamic diameter less than 10 μm; SO2 = sulfur dioxide.

*Income deprivation measures the proportion of the population experiencing income deprivation in an area. Employment deprivation measures deprivation conceptualized as involuntary exclusion of the working-age population from the labor market. Education deprivation measures the extent of deprivation in terms of education, skills, and training in a local area.

Proportion of total variation explained by between-practice differences.

Of the 835,607 patients with linked census data, successful postcode linkage to all pollutants was made for approximately 99% of patients (Table 1). There was significant variation in modeled pollution concentrations by practice region (P < 0.001). Practices in southern England (excluding Greater London) had the lowest annual concentrations of all pollutants except O3. By contrast, practices within Greater London had the highest concentrations for PM10, PM2.5, and NO2, the latter over 70% higher than other southern practices (33.3 vs. 19.4 μg/m3). Areas with a lower SES (higher census deprivation scores of income, employment, and education) were associated with higher concentrations for all pollutants except O3. Within our cohort, annual concentrations of PM10 and PM2.5 were both strongly correlated with NO2 (r = 0.9); moderately correlated with SO2 (r = 0.5); and negatively correlated with O3 (r = −0.5).

A total of 83,103 deaths (9.9% of all patients) were recorded between January 1, 2003 and December 31, 2007 with an underlying cause of death recorded in 80,505 (97%). There were 28,976 (35%) deaths from circulatory; 10,583 (13%) from respiratory; and 5,273 (6%) from lung cancer causes. A total of 37,443 (45%) had some mention of cardiovascular disease on the death certificate. Of all respiratory deaths, 7,740 (73%) had no mention of cardiovascular disease on the death certificate. Higher, age- and sex-adjusted, mortality rates were associated with greater deprivation, living in the North, abnormal BMI, and recorded smoking intensity at baseline (Table 2).

TABLE 2. AGE-SEX ADJUSTED PERCENTAGES OF PATIENTS WHO DIE DURING FOLLOW-UP BY BASELINE FACTORS (N = 835,607)

Baseline VariablesLevelNo. PatientsNo. DeathsAdj %*
SexMale404,71641,20710.2%
 Female430,89141,8969.7%
Age40–49242,2673,1951.3%
 50–59227,9727,2453.2%
 60–69165,83813,0487.9%
 70–79128,17926,58520.7%
 80-8971,35133,03046.3%
SmokingNon386,59131,4048.0%
 Ex (unknown)75,78511,18610.0%
 Ex (1–19 cigs/d)54,3446,57210.7%
 Ex (20–39 cigs/d)26,3823,18412.3%
 Ex (40+ cigs/d)5,22373412.3%
 Current (unknown)17,5062,44511.0%
 Current (1–19 cigs/d)88,2119,39314.1%
 Current (20–39 cigs/d)50,7634,98916.7%
 Current (40+ cigs/d)4,55260219.7%
 Not recorded126,25012,59410.0%
Body mass index<2033,0784,18914.5%
 ≥20 and <25269,92523,2189.2%
 ≥25 and <30243,28923,9509.1%
 ≥30108,96611,63611.4%
 Not recorded180,34920,11010.9%
Practice regionNorth319,45533,63310.7%
 South (excl. London)424,16541,4779.5%
 London91,9877,9939.5%
Income1 (most deprived)104,13713,72412.8%
deprivation2147,78817,75211.3%
quintile3180,38218,4959.9%
 4197,06618,0209.2%
 5 (least deprived)206,23415,1128.2%
Employment1 (most deprived)114,00615,71112.8%
deprivation2149,66317,26410.9%
quintile3170,76417,1569.8%
 4190,69417,2959.2%
 5 (least deprived)210,48015,6778.3%
Education1 (most deprived)120,79515,95912.8%
deprivation2158,95517,76110.9%
quintile3168,46516,5049.7%
 4178,57816,2799.3%
 5 (least deprived)208,81416,6008.3%

*Percentages adjusted to age–sex structure of overall population.

Census-based national rankings.

The relationships between residential air pollution concentrations in 2002 and all-cause mortality during 2003–2007 are shown in Table 3. Associations were positive for all pollutants, except for O3, which were negative. After adjustment for smoking and BMI these ranged from 6–7% for interquartile range increases in PM10, PM2.5, SO2, and NO2, mostly reducing to 2–4% after adjustment for one of the area deprivation markers, with income having the biggest influence. For example, in a model adjusted for area income level, a 1.9 μg/m3 increase in PM2.5 was associated with an HR of 1.02 (95% confidence interval [CI], 1.00–1.05). In two-pollutant models all associations were attenuated, with associations with SO2 proving the most robust (see Table E3).

TABLE 3. HAZARD RATIOS FOR ALL-CAUSE MORTALITY IN 2003–2007 FOR AN INTERQUARTILE RANGE CHANGE IN 2002 POLLUTANT CONCENTRATIONS

 PM10 (n = 830,842)PM2.5 (n = 830,842)SO2 (n = 823,442)NO2 (n = 830,429)O3 (n = 824,654)
Baseline Variables Adjusted ForHR95% CIHR95% CIHR95% CIHR95% CIHR95% CI
+ age, sex1.081.05–1.111.091.06–1.121.071.05–1.091.091.06–1.120.930.90–0.96
+ age, sex, smoking, BMI1.061.04–1.091.071.05–1.101.061.04–1.081.071.04–1.110.940.91–0.96
+ age, sex, smoking, BMI, income*1.021.00–1.041.021.00–1.051.041.03–1.051.031.00–1.050.930.90–0.96
+ age, sex, smoking, BMI, employment*1.041.01–1.061.041.02–1.071.031.02–1.051.041.01–1.070.940.91–0.97
+ age, sex, smoking, BMI, education*1.041.02–1.061.041.02–1.061.031.01–1.051.061.03–1.080.960.93–0.98
10 unit change (income model)1.070.99–1.161.131.00–1.271.201.12–1.281.021.00–1.050.860.78–0.94

Definition of abbreviations: BMI = body mass index; CI = confidence interval; HR = hazard ratio; NO2 = nitrogen dioxide; O3 = ozone; PM2.5 = particulate matter with a median aerodynamic diameter less than 2.5 μm; PM10 = particulate matter with a median aerodynamic diameter less than 10 μm; SO2 = sulfur dioxide.

Number of deaths for each pollutant analysis was as follows: PM10/PM2.5 = 82,475; SO2 = 81,636; NO2 = 82,421; O3 = 81,627. Interquartile ranges for each pollutant were as follows: PM10 = 3.0 μg/m3; PM2.5 = 1.9 μg/m3; SO2 = 2.2 μg/m3; NO2 = 10.7 μg/m3; O3 = 3.0 μg/m3.

*Census deprivation score.

Analyses for specific causes of death (Table 4) revealed that the strongest associations were for respiratory deaths where all pollutants, except O3, were positively associated with increases in mortality. For example, in a model adjusted for area income, a 1.9 μg/m3 increase in PM2.5 was associated with an HR of 1.09 (95% CI, 1.05–1.13), whereas a 3.0 μg/m3 increase in O3 was associated with an HR of 0.94 (95% CI, 0.90–0.97). Comparable HRs were also observed for deaths from COPD and pneumonia (see Table E4). By contrast, there was less evidence of associations with cardiovascular causes of death (Table 4), where only SO2 showed a relationship (HR, 1.04; 95% CI, 1.03–1.06). The pattern was similar with deaths from CHD, myocardial infarction, or stroke, although associations were observed between PM10 and PM2.5 and deaths from heart failure as underlying cause (see Table E4). For lung cancer (Table 4), the strongest associations were seen with NO2 (HR, 1.06; 95% CI, 1.00–1.12). Extending the definition of cardiovascular deaths to any mention on the death certificate, combining them with respiratory deaths, or restricting the definition of respiratory deaths to those without mention of cardiovascular disease, did not materially alter the above findings (see Table E5).

TABLE 4. HAZARD RATIOS FOR SPECIFIC CAUSES OF MORTALITY IN 2003–2007 FOR AN INTERQUARTILE RANGE CHANGE IN 2002 POLLUTANT CONCENTRATIONS

 PM10 (n = 830,842)PM2.5 (n = 830,842)SO2 (n = 823,442)NO2 (n = 830,429)O3 (n = 824,654)
Cause of Death and Baseline Variables Adjusted ForHR95% CIHR95% CIHR95% CIHR95% CIHR95% CI
Circulatory*          
 + age, sex1.061.03–1.091.071.03–1.101.071.05–1.091.071.03–1.100.940.91–0.97
 + age, sex, smoking, BMI1.051.02–1.081.051.02–1.091.061.04–1.081.051.02–1.090.950.92–0.97
 + age, sex, smoking, BMI, income1.000.97–1.031.000.97–1.031.041.03–1.061.000.97–1.030.960.94–0.99
 + age, sex, smoking, BMI, education1.020.99–1.041.021.00–1.051.031.01–1.051.031.00–1.070.960.94–0.98
Respiratory*          
 + age, sex1.191.14–1.241.201.15–1.251.131.09–1.171.221.16–1.270.890.85–0.94
 + age, sex, smoking, BMI1.161.12–1.211.171.12–1.221.121.09–1.151.171.12–1.230.910.87–0.95
 + age, sex, smoking, BMI, income1.081.04–1.121.091.05–1.131.091.06–1.121.091.04–1.140.940.90–0.97
 + age, sex, smoking, BMI, education1.111.08–1.151.121.08–1.161.071.04–1.101.151.10–1.200.930.90–0.96
Lung cancer*          
 + age, sex1.121.05–1.201.141.07–1.221.101.05–1.151.201.12–1.270.890.84–0.95
 + age, sex, smoking, BMI1.071.02–1.131.081.03–1.141.071.03–1.111.131.07–1.190.920.88–0.97
 + age, sex, smoking, BMI, income1.010.96–1.061.020.97–1.071.051.01–1.081.061.00–1.120.940.90–0.99
 + age, sex, smoking, BMI, education1.030.98–1.081.040.99–1.091.030.99–1.061.111.05–1.170.940.90–0.98

Definition of abbreviations: BMI = body mass index; CI = confidence interval; HR = hazard ratio; NO2 = nitrogen dioxide; O3 = ozone; PM2.5 = particulate matter with a median aerodynamic diameter less than 2.5 μm; PM10 = particulate matter with a median aerodynamic diameter less than 10 μm; SO2 = sulfur dioxide.

Interquartile ranges for each pollutant were as follows: PM10 = 3.0 μg/m3; PM2.5 = 1.9 μg/m3; SO2 = 2.2μg/m3; NO2 = 10.7 μg/m3; O3 = 3.0 μg/m3.

*Number of deaths for each pollutant analysis was as follows. Circulatory: PM10/PM2.5 = 28,743; SO2 = 28,441; NO2 = 28,726; O3 = 28,427. Respiratory: PM10/PM2.5 = 10,508; SO2 = 10,408; NO2 = 10,500; O3 = 10,437. Lung cancer: PM10/PM2.5 = 5,244; SO2 = 5,192; NO2 = 5,241; O3 = 5,210.

Census deprivation score. Results adjusting for employment were similar to those adjusting for education (data not shown).

Further analyses of the association with respiratory deaths by selected covariates showed that for PM2.5, PM10, and NO2 there was still evidence of a relationship with respiratory mortality in younger ages (40–64 yr), nonsmokers, and those without any COPD or asthma at baseline (see Table E6). For example, for PM2.5 a 1.9 μg/m3 increase produced an HR of 1.14 (95% CI, 1.08–1.20) for patients classed as nonsmokers at baseline. The association was strongest in more income-deprived areas for PM10, PM2.5, and NO2, but highest for SO2 in least-deprived areas.

Adjustment for within-practice clustering using frailty models attenuated the associations for all pollutants, especially for PM10 and PM2.5 when also adjusted for area income (see Table E7). However, the associations between the pollutants and respiratory mortality remained robust (e.g., for PM2.5 a 1.9 μg/m3 increase produced an HR of 1.07; 95% CI, 1.03–1.11).

This study of a national cohort has observed associations between annual concentrations of ambient air pollution and risk of subsequent death. These relationships were robust to adjustment for smoking and BMI, but attenuated when adjusting for small area SES markers. For cause-specific mortality, associations were larger for respiratory mortality and closer to unity for cardiovascular mortality. Associations with respiratory mortality were also found in nonsmokers and those without COPD or asthma at baseline.

Cohort studies of long-term exposure to air pollution and mortality are predominately based in the United States and have tended to focus on fine particulate matter (PM2.5) (4, 6, 2734). A 2010 review by the American Heart Association (2) reported HRs for PM2.5 and all-cause mortality ranging from 0.99–1.21 per 10 μg/m3, whereas a systematic review in 2008 calculated a pooled relative risk of 1.06 (1). Our estimate when scaled to a 10 μg/m3 increment, and adjusted for area income, produced an HR of 1.13 (95% CI, 1.00–1.27).

Previous cohort studies have tended to emphasize associations with cardiovascular disease, in part because respiratory deaths are far fewer (4, 12) and in part because cardiovascular risks were found to be greater than respiratory (7, 35). US cohort studies of cardiovascular deaths and PM2.5 have reported HRs (per 10 μg/m3) in the range 1.12 (35) to 1.76 (30). Our finding of 1.01 for PM2.5 (when adjusted for income) is considerably lower and is more in line with the two European studies (13, 15) listed in the American Heart Association review (2), which reported associations closer to 1.00. The only cardiovascular subgroup in our study to show evidence of an association with PM2.5 was heart failure deaths. This corresponds to our analysis of disease incidence based on the same cohort (23). We have no firm explanation for the weaker associations between PM2.5 and CHD in our study as compared with the ACS (8). Both studies used standard ICD coding of death certificates as the outcome but there remains the possibility of differences in the certification practice of clinicians. Other relevant differences to consider include time period; population characteristics (including the likely greater use of statins among our patients with CHD); pollution sources; and the spatial scale of the pollution model.

In contrast to the results for cardiovascular mortality, we observed larger and more robust associations with respiratory mortality. Cohort studies that investigated respiratory mortality, summarized in Table 5, have generally reported HR or risk ratios in excess of one, although many have lacked statistical power. The California Teachers Study focused results on cardiovascular rather than respiratory mortality, despite comparable HRs (36). The largest US study (the ACS) initially reported an HR of 0.92 (35); however, a more recent analysis based on almost twice as many respiratory deaths reported an HR of 1.03 (37). Elsewhere, population studies in Norway (13), Japan (18), New Zealand (17), and China (38) have all reported statistically significant, positive associations with respiratory mortality. In the United Kingdom, a national ecologic study (39) reported larger effects of black smoke (a reflectance measure of black carbon particles <4 μm in diameter) on respiratory mortality (HR, 1.19) in the most recent exposure periods (1990–1994), whereas a Scottish study (40) also found larger relationships with respiratory mortality (HR, 1.26). Our scaled findings for PM10 and PM2.5 (HR, 1.30 and 1.54, respectively, per 10 μg/m3) adjusted for area income deprivation exceed all but one (38) of the reported estimates in Table 5; however, we note the smaller mean and standard deviation of our modeled concentrations compared with other studies.

TABLE 5. RESULTS FROM PUBLISHED COHORT STUDIES OF LONG-TERM EXPOSURE TO PARTICULATE MATTER AND RESPIRATORY MORTALITY

StudySettingNAge (yr)Definition of Respiratory DiseaseNo. of Respiratory DeathsExposure YearsMean Exposure (μg/m3) (SD)Key AdjustmentsHR per 10 μg/m395% CI per 10 μg/m3
PM10          
 Abbey et al., 1999 (27)California, United States6,338 (nonsmokers)27–95ICD-9: 460–5192721973–199251.3 (16.6)Past smoking, education, BMI, exercise1.060.99–1.15
 Naess et al., 2007 (13)Oslo, Norway143,84251–90ICD-10: J40–J471,4551992–1995Range, 6.6–30.1Occupation, education1.06–1.28n/a
 Hales et al., 2010 (17)New Zealand1,051,46430–74ICD-9: 162, 470-478, 490-5193,2131995–20018.3 (8.4)Smoking, BMI, census SES1.141.05–1.23
 Lipsett et al., 2011 (36)California, United States61,181 (female teachers)20–80+ICD-9: 460–519 & ICD-10: J00-J984531996–200529.2 (9.7)Smoking, BMI, exercise, census SES1.080.98–1.19
 Hart et al., 2011 (34)United States53,814 (male truckers)15–85ICD-10: J10–18, J40–J983171985–200026.8 (6.0)Census region1.040.85–1.27
 Dong et al., 2012 (38)Shenyang, China9,94135–103ICD-10: J00-J99721998–2009154 (41)Smoking, education, income, BMI, exercise1.671.60–1.74
 Present studyUnited Kingdom831,78840–89ICD-10: J00-J9910,518200219.8 (2.3)Smoking, BMI, income1.301.15–1.47
PM2.5          
 Naess et al., 2007 (13)Oslo, Norway143,84251–90ICD-10: J40–J47 (COPD)1,4551992–1995Range, 6.6–22.3Occupation, education1.07–1.41n/a
 Beelen et al., 2008 (15)Netherlands117,52858–67ICD-10: J00-J999041987–199628.3 (3.1)Smoking, education, BMI, diet1.070.75–1.52
 Jerrett et al., 2009 (37)United States448,85030+ICD-9: 460–5199,8911999–200013.8 (n/a)Smoking, education, BMI, exercise1.030.96–1.11
 Katanoda et al., 2011 (18)Japan63,520 (no baseline respiratory disease)40–70+ICD-9: 460–5196771974–1983Area range, 16.8–41.9Smoking, occupation1.161.04–1.30
 Lipsett et al., 2011 (36)California, United States73,489 (female teachers)20–80+ICD-9: 460–519 and ICD-10: J00-J984041996–200515.6 (4.5)Smoking, BMI, exercise, census SES1.210.97–1.52
 Hart et al., 2011 (34)United States53,814 (male truckers)15–85ICD-10: J10–18, J40–J983171985–200026.8 (6.0)Census region1.180.91–1.54
 Lepeule et al., 2012 (9)Six cities, United States8,09625–74ICD-10: J40–J47 (COPD)2471974–200915.9 (n/a)Smoking, education, BMI1.170.85–1.62
 Cesaroni et al., 2013 (16)Rome, Italy1,265,05830+ICD-9: 460-5198,825200523.0 (4.4)Education, occupation, census SES1.030.97–1.08
 Present studyUnited Kingdom831,78840–89ICD-10: J00-J9910,518200212.9 (1.4)Smoking, BMI, income1.541.27–1.86
Black smoke          
 Elliot et al., 2007 (39)United Kingdom662,34330+ICD-9: 460–5198,4711990–199413.3 (5.3)Area SES1.191.05–1.36
 Beelen et al., 2008 (15)Netherlands117,52858–67ICD-10: J00-J999041987–199613.9 (2.2)Smoking, education, BMI, diet1.220.99–1.50
 Yap et al., 2012 (40)Scotland*15,188/6,29945–64/35–64ICD-9: 480-487, 490-496, 786.0, 786.2606/1741970–197919.3 (3.9)/23.2 (7.5)Smoking, BMI, social class, blood pressure1.26/0.971.02–1.55/0.79–1.18
Total suspended particles          
 Cao et al., 2011 (19)China70,94740+ICD-9: “Respiratory”9211991–2000289Smoking, education, BMI, exercise1.000.99–1.03

Definition of abbreviations: BMI = body mass index; CI = confidence interval; COPD = chronic obstructive pulmonary disease; HR = hazard ratio; ICD = International Classification of Diseases; PM2.5 = particulate matter with a median aerodynamic diameter less than 2.5 μm; PM10 = particulate matter with a median aerodynamic diameter less than 10 μm; SES = socioeconomic status.

Where a study has produced multiple estimates over time (e.g. American Cancer Society), we have only included the most recent estimate.

*Study included two separate cohorts, so both sets of results are included.

This was not a cohort study, and so relative risk is given.

Our associations with respiratory mortality were similar if we further subcategorized into COPD and pneumonia, each representing about 40% of all respiratory deaths. A Norwegian study (13) found positive associations for PM2.5 and PM10 across different age and sex groups for COPD death (Table 5), whereas the ACS (35) and a Japanese study (18) reported positive associations with pneumonia but not COPD. Our associations with respiratory mortality were found in patients classed as nonsmokers, and those without COPD or asthma at the study outset. Other studies have reported little variation of their association with respiratory mortality across their smoking groups (27, 36, 38), or have lacked power to test this (35). A Japanese study (18) demonstrated an effect of PM2.5 on respiratory mortality in female never-smokers (HR, 1.29). Only a Dutch study (15) reported stronger relationships for respiratory mortality and pollution exposure (in this case black smoke) in current smokers.

The evidence from cohort studies for an association between SO2 and mortality is mixed (1). In the ACS reanalysis (8), SO2 was associated with all-cause, cardiopulmonary, and ischemic heart disease mortality, and coefficients for fine particles and mortality were markedly reduced when SO2 was included as a covariate (5). Our robust findings resonate with a UK study that found long-term associations between SO2 and mortality (39), and found larger effects with respiratory deaths. Recent cohort studies from Japan (18) and China (19) have also reported associations with respiratory mortality, contrasting with earlier studies that found little evidence (15, 27). The causal nature of associations between SO2 and mortality have been questioned in part because of the correlation between sulfur dioxide and particles and the lack of persuasive hypotheses linking exposure to low concentrations of sulfur dioxide and death (41).

NO2 has been associated with increased all-cause mortality in some (11, 12, 15, 34, 38) but not all cohort studies (8, 36). Some studies have reported greater effects for respiratory deaths alone (15, 18, 34, 38). A large Dutch cohort found moderate associations with all-cause mortality (HR, 1.03 scaled to a 10 μg/m3 change), and larger associations with respiratory mortality (HR, 1.12) (15), which compares closely with 3% and 9% increases in our adjusted HRs for a similar incremental change. Similarly to the Dutch study (15), we also found no associations with cardiovascular mortality, unlike US studies, which reported positive associations for CHD (8, 34, 36), or a small German study that found elevated effects for cardiopulmonary, of which over 90% were cardiovascular deaths (12).

Evidence for long-term health effects of exposure to ozone has come exclusively from US cohorts (8, 27, 29, 36, 37, 42); however, the picture has not been consistent. A study of nonsmokers found raised HR between mean monthly O3 concentrations and respiratory mortality but lacked precision (27). Extensive analyses of the ACS suggested small, long-term associations with mortality for summer, but not annual, ozone concentrations (8). A further analysis involving two-pollutant models including particles (PM2.5) suggested associations with summer ozone persisted only for respiratory mortality (37), whereas another found relationships with cardiopulmonary mortality alone (42). Our data found negative associations with mortality irrespective of cause, which may be partly explained by negative correlations between ozone and the other pollutants; however, they were not completely explained away in two pollutant models. Because there was little variation within our practice clusters, the modeled O3 concentrations may be largely representing regional levels, where ozone was higher in southern England, where mortality is lower. Because ozone is a highly seasonal pollutant and its production depends on the presence of precursors and sunlight, a metric based on summer ozone concentrations might have been more discriminatory and informative (8).

In our study, air pollution concentrations were derived from emission-based dispersion models, which potentially improve on other methods, such as geostatistical interpolation and land use regression (43) but depend on the quality of data used. A comparison of modeling methods using a large Dutch cohort concluded that dispersion models performed favorably compared with land use regression (44). We have previously applied these models in cross-sectional analyses of national English health survey data (45) and they have been used extensively by the UK Government for reporting to the European Commission (25) and for policy purposes including burden estimation (26).

We have previously discussed the performance and validation of these models (23), and provide further details in the online supplement. Briefly, external validation of the model with monitoring sites in 2002 suggested better modeling of NO2 compared with PM10 and SO2. Because of a limited number of monitoring sites, model validation statistics for PM2.5 were not available until 2009; however, the modeling for PM10 and PM2.5 uses the same general methodology and model performance was similar between the two. The better relative performance of NO2 is perhaps not surprising, because of the complexity of the PM mixture for which the sources are not well characterized. Although this suggests greater confidence in results for NO2, we have emphasized our results with PM2.5 because it is the most important regulated pollutant, is regarded as more likely to be causal, and is commonly used for health impact assessments. The R2 reported for NO2 and PM10 were comparable with those found in a study using land use regression models to estimate concentrations in the United Kingdom in 2001 (46).

Misclassification is also likely to have resulted from assigning pollution estimates at a 1 km2 resolution. Although misclassification of exposure will likely bias effect estimates toward the null (47), and may explain the lack of associations found with cardiovascular mortality, it seems unlikely to explain why stronger associations were found with respiratory mortality. The exposure estimates used for existing cohort studies vary from those that are at a larger community level spatial scale (4, 6, 48) to those where the estimate is at the residential address (13, 16). Our study therefore lies somewhere between the two, and it is possible that this may explain some of the differences between our results and those of other cohorts.

One of the strengths of our study was that it incorporated data from the clinical record, and linked in deaths from a national data collection system. Although we adjusted for individual confounders, such as smoking, misclassification may have arisen, either because of missing values or because of patients being incorrectly classed as nonsmokers on their medical record. Even if recorded correctly, our variable fails to quantify the lifetime burden of current or ex-smokers. Although this limits the precision of our smoking adjustment, it seems unlikely to completely explain away associations seen in nonsmokers.

Although we were unable to adjust for individual socioeconomic markers, neighborhood indicators of socioeconomic deprivation have been shown to be acceptable proxies (49). In our models, this adjustment attenuated all air pollution associations especially with cardiovascular mortality. Because the SES indices may be measured on a smaller geographic scale than our modeled pollution in urban areas, they could be representing concentration gradients not captured by the pollution models. However, given the modest correlations that exist nationally between SES and pollution concentrations, it seems unlikely that the SES indices are over adjusting and erroneously explaining all of the associations observed. Indeed, even if this was not the case for associations with cardiovascular mortality, it cannot explain the stronger associations we found with respiratory mortality before and after SES adjustment. Although we found patients in more socially deprived areas have higher pollution concentrations (except ozone), this contrasted with the ACS (8) where similar census variables were not strongly related, and subsequently had little impact on their effect estimates. In a national Canadian cohort (48), higher concentrations were found in more affluent areas, and HRs associated with exposure to PM2.5 increased after socioeconomic adjustment.

The potential limitations of using cause of death coding from death certificates to classify respiratory deaths has been identified by others (35). For example, a patient with their cause of death listed as pneumonia might have warranted a more appropriate underlying cause of death from long-term chronic conditions, such as CHD, stroke, or COPD (50). A recent report estimated that among all deaths in England and Wales, respiratory deaths are overrecorded by 7%, whereas circulatory deaths are underrecorded by 6% (51). However, for such misclassification to explain a spurious relationship with respiratory deaths and the absence of one with cardiovascular deaths, it requires that virtually all the excess deaths caused by air pollution were those being misclassified, and at a greater rate than the report suggested. Such a scenario seems unlikely. However, to account for potential misclassification we performed sensitivity analyses, which included any mention of circulatory death on the certificate, and restricted respiratory deaths to those with no mention of cardiovascular disease. These showed similar patterns to the underlying cause analyses, suggesting misclassification was unlikely to explain stronger associations with respiratory death. We also noted that associations with respiratory deaths remained when analyses were restricted to younger patients, who will have less comorbidity, and thus the issue of miscoding on their death certificate may be less relevant.

Because of the anonymous nature of the data, we were unable to investigate spatial autocorrelation beyond adjusting for clustering by practice. Patients from the same practice are likely to be more similar to each other than patients from different practices, and this has implications for the precision of our estimates. We chose to conservatively account for this by using the modified sandwich estimate of variance to produce standard errors, which are robust to within practice correlation. As a sensitivity analysis we considered shared frailty models, which fit a random effect to explicitly model this correlation, and found an attenuation of all estimates. A similar attenuation was seen with other modeling approaches that estimated the within cluster effect by accounting for the mean practice concentration level or stratifying the model by practice (data not shown). The implication may be that differences in overall practice area concentrations are driving many of the associations, which is not surprising because this is where most of the variation in the pollution model arises. Although we advise caution when extrapolating our estimates to population impact calculations, we note that our associations with respiratory mortality remained whatever the approach.

This population-based, nationally representative English cohort extends the body of evidence linking air pollution to all-cause mortality but contrary to a number of studies from the United States and elsewhere found that the effects on respiratory mortality were greater than on cardiovascular mortality. When the evidence from existing published cohorts is considered as a whole it seems that there is important heterogeneity in the results for cause-specific mortality. The reasons may lie in differences in various aspects of the methods of investigation, population susceptibility, or toxicity of the air pollution mixture but remain to be elucidated.

The views expressed in this paper are those of the authors and do not reflect the official policy or position of the Medicines and Healthcare Products Regulatory Agency (MHRA). Clinical Practice Research Datalink is owned by the Secretary of State of the UK Department of Health and operates within the MHRA. Clinical Practice Research Datalink has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organizations, and pharmaceutical companies.

1. Chen H, Goldberg MS, Villeneuve PJ. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev Environ Health 2008;23:243297.
2. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, et al.; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010;121:23312378.
3. Pope CA III, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995;151:669674.
4. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:17531759.
5. Health Effects Institute. Reanalysis of the Harvard Six Cities Study and the American Cancer Society study of particulate air pollution and mortality. 2000.
6. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:11321141.
7. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006;173:667672.
8. Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, Turner MC, Pope CA III, Thurston G, Calle EE, et al. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst 2009;140:5114, discussion 115–136.
9. Lepeule J, Laden F, Dockery D, Schwartz J. Chronic exposure to fine particles and mortality: an extended follow-up of the Harvard Six Cities study from 1974 to 2009. Environ Health Perspect 2012;120:965970.
10. Nafstad P, Håheim LL, Oftedal B, Gram F, Holme I, Hjermann I, Leren P. Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men. Thorax 2003;58:10711076.
11. Filleul L, Rondeau V, Vandentorren S, Le Moual N, Cantagrel A, Annesi-Maesano I, Charpin D, Declercq C, Neukirch F, Paris C, et al. Twenty five year mortality and air pollution: results from the French PAARC survey. Occup Environ Med 2005;62:453460.
12. Gehring U, Heinrich J, Krämer U, Grote V, Hochadel M, Sugiri D, Kraft M, Rauchfuss K, Eberwein HG, Wichmann HE. Long-term exposure to ambient air pollution and cardiopulmonary mortality in women. Epidemiology 2006;17:545551.
13. Naess O, Nafstad P, Aamodt G, Claussen B, Rosland P. Relation between concentration of air pollution and cause-specific mortality: four-year exposures to nitrogen dioxide and particulate matter pollutants in 470 neighborhoods in Oslo, Norway. Am J Epidemiol 2007;165:435443.
14. Rosenlund M, Picciotto S, Forastiere F, Stafoggia M, Perucci CA. Traffic-related air pollution in relation to incidence and prognosis of coronary heart disease. Epidemiology 2008;19:121128.
15. Beelen R, Hoek G, van den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, Jerrett M, Hughes E, Armstrong B, Brunekreef B. Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environ Health Perspect 2008;116:196202.
16. Cesaroni G, Badaloni C, Gariazzo C, Stafoggia M, Sozzi R, Davoli M, Forastiere F. Long-term exposure to urban air pollution and mortality in a cohort of more than a million adults in Rome. Environ Health Perspect 2013;121:324331.
17. Hales S, Blakely T, Woodward A. Air pollution and mortality in New Zealand: cohort study. J Epidemiol Community Health 2012;66:468473.
18. Katanoda K, Sobue T, Satoh H, Tajima K, Suzuki T, Nakatsuka H, Takezaki T, Nakayama T, Nitta H, Tanabe K, et al. An association between long-term exposure to ambient air pollution and mortality from lung cancer and respiratory diseases in Japan. J Epidemiol 2011;21:132143.
19. Cao J, Yang C, Li J, Chen R, Chen B, Gu D, Kan H. Association between long-term exposure to outdoor air pollution and mortality in China: a cohort study. J Hazard Mater 2011;186:15941600.
20. Zhang P, Dong G, Sun B, Zhang L, Chen X, Ma N, Yu F, Guo H, Huang H, Lee YL, et al. Long-term exposure to ambient air pollution and mortality due to cardiovascular disease and cerebrovascular disease in Shenyang, China. PLoS ONE 2011;6:e20827.
21. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:22242260.
22. Medicines and Healthcare Regulatory Agency. The Clinical Practice Research Datalink. 2012 [accessed 14 April 2013]. Available from: http://www.cprd.com.
23. Atkinson RW, Carey IM, Kent AJ, van Staa TP, Anderson HR, Cook DG. Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases. Epidemiology 2013;24:4453.
24. Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English indices of deprivation 2007. London: Department for Communities and Local Government; 2008.
25. Stedman JR, Bush TJ, Vincent KJ, Baggott S. UK air quality modelling for annual reporting 2002 on ambient air quality assessment under Council Directives 96/62/EC, 1999/30/EC and 2000/69/EC. Report AEAT/ENV/R/1564. 2003. Didcot, Oxfordshire. AEA Energy & Environment [accessed 14 April 2013]. Available from: http://uk-air.defra.gov.uk/reports/cat05/0402061100_dd12002mapsrep1-2.pdf
26. Department of Health. The mortality effects of long-term exposure to particulate air pollution in the UK. 2010. Committee on the Medical Effects of Air Pollutants [accessed 2013 Apr 14]. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137012567
27. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999;159:373382.
28. Enstrom JE. Fine particulate air pollution and total mortality among elderly Californians, 1973-2002. Inhal Toxicol 2005;17:803816.
29. Lipfert FW, Baty JD, Miller JP, Wyzga RE. PM2.5 constituents and related air quality variables as predictors of survival in a cohort of U.S. military veterans. Inhal Toxicol 2006;18:645657.
30. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007;356:447458.
31. Puett RC, Schwartz J, Hart JE, Yanosky JD, Speizer FE, Suh H, Paciorek CJ, Neas LM, Laden F. Chronic particulate exposure, mortality, and coronary heart disease in the nurses’ health study. Am J Epidemiol 2008;168:11611168.
32. Eftim SE, Samet JM, Janes H, McDermott A, Dominici F. Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a Medicare cohort. Epidemiology 2008;19:209216.
33. Zeger SL, Dominici F, McDermott A, Samet JM. Mortality in the Medicare population and chronic exposure to fine particulate air pollution in urban centers (2000-2005). Environ Health Perspect 2008;116:16141619.
34. Hart JE, Garshick E, Dockery DW, Smith TJ, Ryan L, Laden F. Long-term ambient multipollutant exposures and mortality. Am J Respir Crit Care Med 2011;183:7378.
35. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004;109:7177.
36. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Jerrett M, Smith DF, Garcia C, Chang ET, Bernstein L. Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med 2011;184:828835.
37. Jerrett M, Burnett RT, Pope CA III, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M. Long-term ozone exposure and mortality. N Engl J Med 2009;360:10851095.
38. Dong GH, Zhang P, Sun B, Zhang L, Chen X, Ma N, Yu F, Guo H, Huang H, Lee YL, et al. Long-term exposure to ambient air pollution and respiratory disease mortality in Shenyang, China: a 12-year population-based retrospective cohort study. Respiration 2012;84:360368.
39. Elliott P, Shaddick G, Wakefield JC, de Hoogh C, Briggs DJ. Long-term associations of outdoor air pollution with mortality in Great Britain. Thorax 2007;62:10881094.
40. Yap C, Beverland IJ, Heal MR, Cohen GR, Robertson C, Henderson DE, Ferguson NS, Hart CL, Morris G, Agius RM. Association between long-term exposure to air pollution and specific causes of mortality in Scotland. Occup Environ Med 2012;69:916924.
41. Department of Health. Long-term exposure to air pollution: effect on mortality. 2009. Committee on the Medical Effects of Air Pollutants [accessed 2013 Apr 14]. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137020526
42. Smith KR, Jerrett M, Anderson HR, Burnett RT, Stone V, Derwent R, Atkinson RW, Cohen A, Shonkoff SB, Krewski D, et al. Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants. Lancet 2009;374:20912103.
43. Jerrett M, Arain A, Kanaroglou P, Beckerman B, Potoglou D, Sahsuvaroglu T, Morrison J, Giovis C. A review and evaluation of intraurban air pollution exposure models. J Expo Anal Environ Epidemiol 2005;15:185204.
44. Beelen R, Voogt M, Duyzer J, Zandveld P, Hoek G. Comparison of the performances of land use regression modelling and dispersion modelling in estimating small-scale variations in long-term air pollution concentrations in a Dutch urban area. Atmos Environ 2010;44:46144621.
45. Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup PH, Strachan DP, Anderson RH. Chronic exposure to outdoor air pollution and markers of systemic inflammation. Epidemiology 2009;20:245253.
46. Vienneau D, de Hoogh K, Beelen R, Fischer P, Hoek G, Briggs D. Comparison of land-use regression models between Great Britain and the Netherlands. Atmos Environ 2010;44:688696.
47. Armstrong BG. Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med 1998;55:651656.
48. Crouse DL, Peters PA, van Donkelaar A, Goldberg MS, Villeneuve PJ, Brion O, Khan S, Atari DO, Jerrett M, Pope CA, et al. Risk of nonaccidental and cardiovascular mortality in relation to long-term exposure to low concentrations of fine particulate matter: a Canadian national-level cohort study. Environ Health Perspect 2012;120:708714.
49. Adams J, Ryan V, White M. How accurate are Townsend Deprivation Scores as predictors of self-reported health? A comparison with individual level data. J Public Health (Oxf) 2005;27:101106.
50. Ayres JG, Propper C, Janke K, Harrision RM. Atmospheric pollution and mortalities in English local authority areas [letter]. J Epidemiol Community Health 2009;63:173.
51. Office for National Statistics. Death certification reform: a case study on the potential impact on mortality statistics. 2012 [accessed 2013 May 17]. Available from: http://www.ons.gov.uk/ons/dcp171778_288141.pdf
Correspondence and requests for reprints should be addressed to Richard W. Atkinson, Ph.D., Division of Population Health Sciences and Education and MRC-PHE Centre for Environment and Health, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK. E-mail:

Supported by Policy Research Programme in the Department of Health.

Author Contributions: Conception and design, I.M.C., R.W.A., A.J.K., T.v.S., D.G.C., and H.R.A. Analysis, interpretation, and drafting of manuscript, I.M.C., R.W.A., D.G.C., and H.R.A.

Originally Published in Press as DOI: 10.1164/rccm.201210-1758OC on April 3, 2013

This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org

Author disclosures are available with the text of this article at www.atsjournals.org.

Related

No related items
American Journal of Respiratory and Critical Care Medicine
187
11

Click to see any corrections or updates and to confirm this is the authentic version of record